Clinical Research Directory
Browse clinical research sites, groups, and studies.
Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy
Sponsor: Thomas Jefferson University
Summary
This goal of this study is to determine whether a novel biologic, i.e., an "amniotic suspension allograft" (ASA) will reduce pain and improve quality of life (QoL) in women stricken with chronic pelvic pain (CPP). The main questions it aims to answer are: * Weather pain in the genitalia is reduced with treatment * Weather bladder or urination pain is reduced with treatment * Weather any adverse events occur following treatment Patient responses to pain and QoL will be collected before and 6-12 months after treatment.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2019-04-01
Completion Date
2024-07-01
Last Updated
2024-05-22
Healthy Volunteers
Not specified
Conditions
Interventions
Amniotic suspension allograft
the amniotic suspension allograft consists of fresh amniotic fluid into which micronized amniotic membrane has been added as a suspension.
Locations (1)
Thomas Jefferwson University Hospital
Philadelphia, Pennsylvania, United States